Functional characterization, localization, and inhibitor sensitivity of the <scp>TPR‐FGFR1</scp> fusion in 8p11 myeloproliferative syndromeTheodora Malli, Gerald Webersinke, Veronika Buxhofer‐Ausch et al.|Genes Chromosomes and Cancer|2015Cited by 15
A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha‐2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)—AGMT_CML 1Sonja Heibl, Josef Thaler, Thomas Lion et al.|Hematological Oncology|2020Cited by 11
Successful kidney transplantation in a patient with pre-existing chronic myeloid leukemia treated with imatinibUrsula Thiem, Daniel Cejka, Veronika Buxhofer‐Ausch et al.|American Journal of Transplantation|2020Cited by 8
Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen—Single-Center AnalysisSigrid Machherndl‐Spandl, Veronika Buxhofer‐Ausch, Sarah Hannouf et al.|Cancers|2024Cited by 4
Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic MyelofibrosisSigrid Machherndl‐Spandl, Veronika Buxhofer‐Ausch, Marcel Kiehberger et al.|Cancers|2025Cited by 1